Novartis | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 27.68B 2.09B 2025-03
Amgen USD 26.73B 195M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Bausch Health Companies USD 6.51B 782M 2025-06
Biogen USD 7.97B 341.7M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 49.85B 8.59B 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
Glaxosmithkline GBP 17B 301M 2024-12
J&J USD 71.55B 15.66B 2025-03
Merck USD 37.07B 1.56B 2025-06
Novartis USD 25.94B 831M 2025-06
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 745.61M 14.35M 2025-06
Perrigo USD 2.62B 82M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Prestige Brands USD 480.52M 32.19M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 37.02B 7B 2025-06
Sanofi 42.59B 12.51B 2024-12
Supernus Pharmaceuticals USD 738.87M 51.28M 2025-06
Zoetis USD 5.92B 46M 2025-06


Novartis Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.